HepaGam B 312 [iU]/mL
HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN · INJECTION, SOLUTION · Kamada Ltd.
HepaGam B is a injection, solution containing human hepatitis b virus immune globulin at 312 [iU]/mL, taken intramuscular. Manufactured by Kamada Ltd..
Key Facts
- Brand Name
- HepaGam B
- Generic Name
- HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN
- NDC Code (Product)
49591-052- Manufacturer
- Kamada Ltd.
- Strength
- 312 [iU]/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Marketing Status
- Application #
- BLA125035
- Marketing Start
- 10/01/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is HepaGam B used for?
HepaGam B contains HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN. It is a injection, solution taken intramuscular. Consult your doctor for specific uses.
Is HepaGam B a controlled substance?
HepaGam B is not classified as a controlled substance by the DEA.
What is the generic name for HepaGam B?
The generic name for HepaGam B is HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN. There are no other listed brand versions of HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN.
What is the NDC code for HepaGam B 312 [iU]/mL?
The NDC (National Drug Code) for HepaGam B 312 [iU]/mL is 49591-052, listed by Kamada Ltd..
Other HepaGam B Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)